Gary R. Pettit

Gary R. Pettit is an experienced sales professional in the biotechnology and pharmaceutical sectors. Currently serving as a Regional Sales Manager at Neurocrine Biosciences since September 2016, Gary R. Pettit successfully launched the first treatment for tardive dyskinesia and built a national sales team of 214 representatives, contributing to the approval of a new Parkinson's Disease therapeutic in mid-2020. Previously, as Regional Business Director at Sanofi Genzyme from June 2012 to September 2016, Gary R. Pettit ranked among the top regional directors. Prior experience includes roles at Biogen, Boston Scientific, Cephalon, Bayer, and SRAM, with a focus on neurology products, surgical devices, and sales management. Gary R. Pettit holds a BS and BA in International Relations and German from Brigham Young University.